We have located links that may give you full text access.
Journal Article
Research Support, Non-U.S. Gov't
Cationic bis-cyclometallated iridium(III) phenanthroline complexes with pendant fluorenyl substituents: synthesis, redox, photophysical properties and light-emitting cells.
We report the synthesis, characterisation, photophysical and electrochemical properties of a series of cationic cyclometallated Ir(III) complexes of general formula [Ir(ppy)(2)(phen)]PF(6) (ppy=2-phenylpyridine, phen=a substituted phenanthroline). A feature of these complexes is that the phen ligands are substituted with one or two 9,9-dihexylfluorenyl substituents to provide extended pi conjugation, for example, the 3-[2-(9,9-dihexylfluorenyl)]phenanthroline and 3,8-bis[2-(9,9-dihexylfluorenyl)]phenanthroline ligands afford complexes 6 and 9, respectively. A single-crystal X-ray diffraction study of a related complex 18 containing the 3,8-bis(4-iodophenyl)phenanthroline ligand, revealed an octahedral coordination of the Ir atom, in which the metallated C atoms of the ppy ligands occupy cis positions. The complexes 6 and 9 displayed reversible oxidation waves in cyclic voltammetric studies (E(ox)(1/2)=+1.18 and +1.20 V, respectively, versus Ag/Ag(+) in CH(2)Cl(2)) assigned to the metal-centred Ir(III)/Ir(IV) couple. The complexes exhibit strong absorption in the UV region in solution spectra, due to spin-allowed ligand-centred (LC) (1)pi-pi* transitions; moderately intense bands occur at approximately 360-390 nm which are red-shifted with increased ligand length. The photoluminescence spectra of all the complexes were characterised by a broad band at lambda(max) approximately 595 nm assigned to a combination of (3)MLCT and (3)pi-->pi* states. The long emission lifetimes (in the microsecond time-scale) are indicative of phosphorescence: the increased ligand conjugation length in complexes 9 and 17 leads to increased lifetimes for the complexes (tau=2.56 and 2.57 micros in MeCN, respectively) compared to monofluorenyl analogues 6 and 15 (tau=1.43 and 1.39 micros, respectively). DFT calculations of the geometries and electronic structures of complexes 6', 9' (for both singlet ground state (S(0)) and triplet first excited (T(1)) states) and 18 have been performed. In the singlet ground state (S(0)) HOMO orbitals in the complexes are spread between the Ir atom and benzene rings of the phenylpyridine ligand, whereas the LUMO is mainly located on the phenanthroline ligand. Analysis of orbital localisations for the first excited (T(1)) state have been performed and compared with spectroscopic data. Spin-coated light-emitting cells (LECs) have been fabricated with the device structures ITO/PEDOT:PSS/Ir complex/Al, or Ba capped with Al (ITO=indium tin oxide, PEDOT=poly(3,4-ethylenedioxythiophene), PSS=poly(styrene) sulfonate). A maximum brightness efficiency of 9 cd A(-1) has been attained at a bias of 9 V for 17 with a Ba/Al cathode. The devices operated in air with no reduction in efficiency after storage for one week in air.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app